Zinnia P Use In Pregnancy & Lactation

Levonorgestrel 150 mcg and Ethinylestradiol 30 mcg Tablets with Inert Tablets are not indicated during pregnancy. If pregnancy occurs during treatment with Levonorgestrel 150 mcg and Ethinylestradiol 30 mcg Tablets with Inert Tablets, further intake must be stopped. However, extensive epidemiological studies have revealed neither an increased risk of birth defects in children born to women who used COCs prior to pregnancy, nor a teratogenic effect when COCs were taken inadvertently during early pregnancy.
The increased risk of VTE during the postpartum period should be considered when re-starting Levonorgestrel 150 mcg and Ethinylestradiol 30 mcg Tablets with Inert Tablets (see Dosage & Administration and Precautions).
The use of Levonorgestrel 150 mcg and Ethinylestradiol 30 mcg Tablets with Inert Tablets during lactation may lead to a reduction in the volume of milk produced and to a change in its composition. Minute amounts of the active substances are excreted with the milk. These amounts may affect the child particularly in the first 6 weeks post-partum. Mothers who are breast-feeding may be advised instead to use another method of contraception.